Nitrous Oxide Inhalation Prevention Act
A bill to set forth requirements for the regulation by the Food and Drug Administration of nitrous oxide products, and for other purposes.
This bill aims to establish specific regulations for nitrous oxide products by the Food and Drug Administration (FDA). It was introduced on July 15, 2026, by Ron Wyden, Richard Blumenthal, and Alex Padilla. The bill seeks to ensure that nitrous oxide products are safe and properly labeled for consumers.
This legislation would primarily affect manufacturers, distributors, and consumers of nitrous oxide products. It would require these entities to comply with new FDA regulations, potentially impacting how nitrous oxide is marketed, sold, and used. The goal is to enhance safety and prevent misuse of these products.
As of July 15, 2026, the bill has been introduced and referred to the Senate Committee on Health, Education, Labor, and Pensions. This is the first step in the legislative process, where the bill will be reviewed and potentially undergo amendments before further action.
